Introduction to NDC 68462-0135
The National Drug Code (NDC) 68462-0135 corresponds to Abiraterone Acetate 250 MG tablets, a medication used primarily in the treatment of prostate cancer. Here, we will delve into the market analysis and price projections for this drug.
Drug Overview
Abiraterone Acetate is a critical medication in the oncology segment, particularly for treating metastatic castration-resistant prostate cancer. It is manufactured by various companies, including Glenmark Pharmaceuticals Inc., USA[1].
Current Pricing Trends
As of the latest data, the average pharmacy cost for Abiraterone Acetate 250 MG tablets (NDC 68462-0135) has shown some fluctuations. Here are some recent price points:
- December 2024: $1.07554 per unit
- November 2024: $1.08623 per unit
- October 2024: $0.98375 per unit[1].
These prices indicate a relatively stable market with minor variations.
Wholesale Pricing
Wholesale prices for this drug can vary based on the vendor and the quantity purchased. For example, Glenmark Pharmaceuticals Inc., USA offers a wholesale price of $1.87458 per unit for a pack of 120 tablets[1].
Market Factors Influencing Pricing
Several factors influence the pricing of Abiraterone Acetate and similar pharmaceuticals:
Competition from Generics and Biosimilars
The life sciences industry is seeing increased competition from generic drugs and biosimilars. This competition can drive down prices as more affordable alternatives enter the market. For instance, 37% of life sciences executives view competition from generics and biosimilars as a top trend[3].
Patent Expirations
The biopharma industry is facing a substantial loss of exclusivity due to expiring patents, which can lead to increased generic competition and potentially lower prices. Over $300 billion in sales are at risk through 2030 due to expiring patents on high-revenue products[3].
Research and Development Costs
High R&D costs are a significant factor in drug pricing. Pharmaceutical companies invest heavily in research and development, and these costs are often reflected in the final price of the drug. In 2021, the R&D expenditure of the US pharmaceutical market totaled around $102 billion[4].
Regulatory and Market Dynamics
Regulatory processes, geopolitical uncertainty, and market dynamics also play crucial roles in pricing. Manufacturers often attribute price increases to factors such as rebates, co-pay assistance programs, and obligations to shareholders[2].
Price Projections
Given the current trends and market factors, here are some projections for the future pricing of Abiraterone Acetate:
Short-Term Projections
In the short term, prices are likely to remain relatively stable with minor fluctuations. The competition from generics and the ongoing patent expirations may start to exert downward pressure on prices, but this effect is expected to be gradual.
Long-Term Projections
In the long term, the impact of generic competition and biosimilars is expected to be more pronounced. As more patents expire and generic versions of the drug become more widely available, prices could decrease. The integration of AI and digital technologies in drug discovery and development may also lead to more efficient production processes, potentially reducing costs and prices[4].
Industry Outlook
The US pharmaceutical market, which includes Abiraterone Acetate, is projected to grow significantly. The market is expected to increase from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%[4].
Digital Transformation and Innovation
The life sciences industry is undergoing significant transformation driven by digital advancements and scientific innovations. The use of AI in drug discovery and development is expected to boost operational efficiencies and drive breakthrough innovations, which could impact pricing and market dynamics[3].
Conclusion
The pricing of Abiraterone Acetate (NDC 68462-0135) is influenced by a complex interplay of market factors, including competition from generics, patent expirations, R&D costs, and regulatory dynamics. While short-term prices are expected to remain stable, long-term projections suggest a potential decrease in prices due to increased generic competition and advancements in drug development technologies.
Key Takeaways
- Current Pricing: Stable with minor fluctuations around $1 per unit.
- Wholesale Pricing: Varies by vendor, with Glenmark offering around $1.87 per unit for bulk purchases.
- Market Factors: Competition from generics, patent expirations, R&D costs, and regulatory dynamics.
- Short-Term Projections: Stable prices with minor fluctuations.
- Long-Term Projections: Potential decrease in prices due to generic competition and technological advancements.
- Industry Outlook: Growing US pharmaceutical market driven by digital transformation and innovation.
FAQs
Q: What is the current average pharmacy cost for Abiraterone Acetate 250 MG tablets (NDC 68462-0135)?
A: As of the latest data, the average pharmacy cost is around $1.07554 per unit.
Q: Who manufactures Abiraterone Acetate 250 MG tablets under NDC 68462-0135?
A: Glenmark Pharmaceuticals Inc., USA is one of the manufacturers.
Q: How does competition from generics affect the pricing of Abiraterone Acetate?
A: Increased competition from generics can drive down prices as more affordable alternatives enter the market.
Q: What role do patent expirations play in the pricing of pharmaceuticals like Abiraterone Acetate?
A: Patent expirations can lead to increased generic competition, potentially lowering prices.
Q: How is the use of AI in drug discovery expected to impact the pharmaceutical market?
A: AI is expected to boost operational efficiencies and drive breakthrough innovations, potentially reducing costs and prices.
Sources
- DrugPatentWatch: Latest drug prices and trends for NDC 68462-0135.
- Oregon Drug Price Transparency Report: Prescription Drug Price Transparency Results and Recommendations.
- Deloitte Insights: 2025 life sciences outlook.
- GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030.
